Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery?

Transfusion

Volumn 57, Issue 2, 2017, Pages 440-450

  Zaw, Aye Sandar ^a   Kantharajanna, Shashidhar B ^a   Maharajan, Karthikeyan ^a   Tan, Barry ^a   Vellayappan, Balamurugan ^b   Kumar, Naresh ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b SINGAPORE INSTITUTE OF TECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER GROWTH; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE BLOOD TRANSFUSION; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SPINE TUMOR; AGED; CLINICAL TRIAL; DISEASE FREE SURVIVAL; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PERIOPERATIVE PERIOD; RISK FACTOR; SECONDARY; SPINAL NEOPLASMS; SURVIVAL RATE;

AGED; BLOOD TRANSFUSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL NEOPLASMS; SURVIVAL RATE;

EID: 85005784435     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13912     Document Type: Article

References (48)

1. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. First of two parts—blood transfusion. N Engl J Med 1999;340:438–47.
2. Hu SS. Blood loss in adult spinal surgery. Eur Spine J 2004;13:S3–5.
3. Schiergens TS, Rentsch M, Kasparek MS, et al. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 2015;58:74–82.
4. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859–67.
5. Adair RA, Young AL, Cockbain AJ, et al. Repeat hepatic resection for colorectal liver metastases. Br J Surg 2012;99:1278–83.
6. Haruki K, Shiba H, Fujiwara Y, et al. Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection. J Surg Oncol 2012;106:31–5.
7. Keller SM, Groshen S, Martini N, et al. Blood transfusion and lung cancer recurrence. Cancer 1988;62:606–10.
8. Moriguchi S, Maehara Y, Akazawa K, et al. Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer 1990;66:2331–5.
9. Warschkow R, Güller U, Köberle D, et al. Perioperative blood transfusions do not impact overall and disease-free survival after curative rectal cancer resection: a propensity score analysis. Ann Surg 2014;259:131–8.
10. Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Joint J 2013;95-B:683–8.
11. Kumar N, Zaw AS, Khine HE, et al. Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors. Ann Surg Oncol 2016;23:2079–86.
12. Clausen C, Lönn L, Morgen SS, et al. Perioperative blood transfusion does not decrease survival after surgical treatment of spinal metastases. Eur Spine J 2014;23:1791–6.
13. Paulino Pereira NR, Beks RB, Janssen SJ, et al. Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases? Spine J 2016;16:951–61.
14. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005;30:2186–91.
15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
16. Bilsky MH, Laufer I, Fourney DR, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 2010;13:324–8.
17. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
18. van Persijn van Meerten EL, Gelderblom H, Bloem JL. RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol 2010;20:1456–67.
19. Lecouvet FE, Talbot JN, Messiou C, et al. Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer 2014;50:2519–31.
20. Kumar N, Zaw AS, Reyes MR, et al. Versatility of percutaneous pedicular screw fixation in metastatic spine tumor surgery: a prospective analysis. Ann Surg Oncol 2015;22:1604–11.
21. Holman PJ, Suki D, McCutcheon I, et al. Surgical management of metastatic disease of the lumbar spine: experience with 139 patients. J Neurosurg Spine 2005;2:550–63.
22. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate [letter]. Lancet 1982;2:662.
23. Katoh H, Yamashita K, Kokuba Y, et al. Surgical resection of stage IV colorectal cancer and prognosis. World J Surg 2008;32:1130–7.
24. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860–9. discussion 9-70.
25. Skånberg J, Lundholm K, Haglind E. Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncol 2007;46:1123–30.
26. Luan H, Ye F, Wu L, et al. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis. BMC Surg 2014;14:34.
27. Wang T, Luo L, Huang H, et al. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg 2014;97:1827–37.
28. Crowe JP, Gordon NH, Fry DE, et al. Breast cancer survival and perioperative blood transfusion. Surgery 1989;106:836–41.
29. Cata JP, Lasala J, Pratt G, et al. Association between perioperative blood transfusions and clinical outcomes in patients undergoing bladder cancer surgery: a systematic review and meta-analysis study. J Blood Transfus 2016;2016:9876394
30. Linder BJ, Thompson RH, Leibovich BC, et al. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int 2014;114:368–74.
31. Soubra A, Zabell JR, Adejoro O, et al. Effect of perioperative blood transfusion on mortality for major urologic malignancies. Clin Genitourin Cancer 2014;13:e173–81.
32. Balain B, Jaiswal A, Trivedi JM, et al. The Oswestry Risk Index: an aid in the treatment of metastatic disease of the spine. Bone Joint J 2013;95-B:210–6.
33. Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically? Hematology 2005;10:208–14.
34. Blajchman MA, Bardossy L, Carmen R, et al. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:1880–2.
35. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344–8.
36. Atzil S, Arad M, Glasner A, et al. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology 2008;109:989–97.
37. Lange MM, van Hilten JA, van de Watering LM, et al. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg 2009;96:734–40.
38. van Hilten JA, van de Watering LM, van Bockel JH, et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ 2004;328:1281.
39. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372–6.
40. Janssen SJ, Braun Y, Wood KB, et al. Allogeneic blood transfusions and postoperative infections after lumbar spine surgery. Spine J 2015;15:901–9.
41. Kato S, Chikuda H, Ohya J, et al. Risk of infectious complications associated with blood transfusion in elective spinal surgery—a propensity score matched analysis. Spine J 2016;16:55–60.
42. Seicean A, Alan N, Seicean S, et al. The effect of blood transfusion on short-term, perioperative outcomes in elective spine surgery. J Clin Neurosci 2014;21:1579–85.
43. Woods BI, Rosario BL, Chen A, et al. The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery. J Bone Jt Surg 2013;95:2105–10.
44. World Health Organization. 63rd World Health Assembly: WHA63.12, availability, safety and quality of blood products. May 2010 [cited 2016 Mar 13]. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf.
45. Spahn DR, Shander A, Hofmann A. The chiasm: transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol 2013;27:37–42.
46. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198–208.
47. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015;122:241–75.
48. Watkins T, Surowiecka MK, McCullough J. Transfusion indications for patients with cancer. Cancer Control 2015;22:38–46.